Literature DB >> 6712296

Autoantibodies in the sicca syndrome (primary Sjögren's syndrome).

K B Elkon, A E Gharavi, G R Hughes, H M Moutsoupoulos.   

Abstract

IgA and IgM rheumatoid factors as well as antibodies to Ro and La were measured in 37 patients with the sicca syndrome and 9 patients with Sjögren's syndrome secondary to rheumatoid arthritis. Positive results were found in 84% (IgA rheumatoid factor), 76% (IgM rheumatoid factor), 62% (Ro), and 50% (La) of patients with the sicca syndrome. There was no significant difference in the frequency of positive results in patients with glandular versus extraglandular disease. Antibodies to La invariably occurred in patients with antibodies to Ro. In addition, patients who were anti-Ro positive also had significantly higher IgA (p less than 0.05) and IgM (p less than 0.01) rheumatoid factor activity. Since 81% of the sicca patients were concordant for 3 of the 4 antibodies tested, production of these autoantibodies appears to be related.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6712296      PMCID: PMC1001474          DOI: 10.1136/ard.43.2.243

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

1.  Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis.

Authors:  N Kurata; E M Tan
Journal:  Arthritis Rheum       Date:  1976 May-Jun

2.  Autoantibodies and the spectrum of Sjögren's syndrome.

Authors:  M Martinez-Lavin; J H Vaughan; E M Tan
Journal:  Ann Intern Med       Date:  1979-08       Impact factor: 25.391

3.  Differentiation and characterization of autoantibodies and their antigens in Sjögren's syndrome.

Authors:  M A Alspaugh; N Talal; E M Tan
Journal:  Arthritis Rheum       Date:  1976 Mar-Apr

4.  Demonstration of circulating immune complexes in Sjögren's syndrome.

Authors:  T J Lawley; H M Moutsopoulos; S I Katz; A N Theofilopoulos; T M Chused; M M Frank
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

Review 5.  The histopathology of Sjögren's syndrome in labial salivary gland biopsies.

Authors:  J S Greenspan; T E Daniels; N Talal; R A Sylvester
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1974-02

6.  Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythmatosus.

Authors:  G Clark; M Reichlin; T B Tomasi
Journal:  J Immunol       Date:  1969-01       Impact factor: 5.422

7.  Radioimmunoassay profile of antiglobulins in connective tissue diseases: elevated level of IgA antiglobulin in systemic sicca syndrome.

Authors:  K B Elkon; F Caeiro; A E Gharavi; B M Patel; P P Ferjencik; G R Hughes
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

8.  Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis.

Authors:  H M Moutsopoulos; B L Webber; T P Vlagopoulos; T M Chused; J L Decker
Journal:  Am J Med       Date:  1979-05       Impact factor: 4.965

9.  Sjögren's syndrome (Sicca syndrome): current issues.

Authors:  H M Moutsopoulos; T M Chused; D L Mann; J H Klippel; A S Fauci; M M Frank; T J Lawley; M I Hamburger
Journal:  Ann Intern Med       Date:  1980-02       Impact factor: 25.391

10.  Clinical and serological differences between systemic lupus erythematosus patients with antibodies to Ro versus patients with antibodies to Ro and La.

Authors:  C A Wasicek; M Reichlin
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

View more
  12 in total

1.  Ro/SSA and La/SSB specific IgA autoantibodies in serum of patients with Sjögren's syndrome and systemic lupus erythematosus.

Authors:  N Pourmand; M Wahren-Herlenius; I Gunnarsson; E Svenungsson; B Löfström; Y Ioannou; D A Isenberg; C G Magnusson
Journal:  Ann Rheum Dis       Date:  1999-10       Impact factor: 19.103

2.  The specificity of antiglobulin autoantibodies in patients with primary Sjögren's syndrome.

Authors:  T Wada; I Ezaki; M Shingu; S Nonaka; E Ohtsuka; M Yasuda; M Nobunaga
Journal:  Clin Rheumatol       Date:  1990-12       Impact factor: 2.980

Review 3.  Autoantibodies in Sjögren's Syndrome.

Authors:  Anum Fayyaz; Biji T Kurien; R Hal Scofield
Journal:  Rheum Dis Clin North Am       Date:  2016-06-21       Impact factor: 2.670

4.  Analysis of autoantibodies to recombinant La (SS-B) peptides in systemic lupus erythematosus and primary Sjogren's syndrome.

Authors:  P Bini; J L Chu; C Okolo; K Elkon
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

5.  Clinical significance of chronic hepatitis B virus infection in patients with primary Sjögren's syndrome.

Authors:  Ming-Han Chen; Liang-Tsai Hsiao; Ming-Huang Chen; Chang-Youh Tsai; Yi-Hsiang Huang; Chung-Tei Chou
Journal:  Clin Rheumatol       Date:  2011-08-02       Impact factor: 2.980

Review 6.  Autoantigens as Partners in Initiation and Propagation of Autoimmune Rheumatic Diseases.

Authors:  Antony Rosen; Livia Casciola-Rosen
Journal:  Annu Rev Immunol       Date:  2016-02-22       Impact factor: 28.527

7.  Temporal correlation of antibody responses to different epitopes of the human La autoantigen.

Authors:  E W St Clair; J A Burch; M M Ward; J D Keene; D S Pisetsky
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

8.  Monoclonal process in primary Sjögren's syndrome and cross-reactive idiotype associated with rheumatoid factor.

Authors:  P D Katsikis; P Y Youinou; V Galanopoulou; N M Papadopoulos; A G Tzioufas; H M Moutsopoulos
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

9.  Axonal polyneuropathy without vasculitis, follicular lymphoma and primitive sicca syndrome. A rare association.

Authors:  A Heylen; J P Devogelaer; H Noel; C Nagant De Deuxchaisnes
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

10.  Relationship between retinal morphological findings and autoantibody profile in primary Sjögren's syndrome.

Authors:  Jee Myung Yang; Hwan Heo; Sang Woo Park
Journal:  Jpn J Ophthalmol       Date:  2014-06-03       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.